Korea South
EndoRobotics Co., Ltd., founded in 2019, is a pioneering company at the intersection of the Health Care and Robotics industries, headquartered in Korea South. The company focuses on developing and commercializing cutting-edge robotic technologies specifically designed for advanced therapeutic endoscopy, as encapsulated in their slogan: "Endoscope meets Robotics for Advanced Therapeutic Endoscopy."
With a recent injection of $8.30M from a Series B investment round on 14 August 2023, EndoRobotics is positioned to further enhance its capabilities. This round attracted a cohort of investors including L&S Venture Capital, Partners Investment, Mirae Asset Capital, Pathfinder H, and Donghoon Investment, signaling strong confidence in the company's potential.
EndoRobotics is advancing the landscape of surgical robotics, offering substantial value to an ever-evolving healthcare market and presenting lucrative opportunities for investors seeking innovation in medical technology.
